Journal Details

Product description

The Brazilian Journal of Oncology (ISSN 2526-8732) is the successor to the Revista Brasileira de Oncologia Clínica (ISSN 1806-6054), a print journal previously managed by the Sociedade Brasileira de Oncologia Clínica (Brazilian Society of Clinical Oncology), which released its inaugural issue in April 2004.

The Journal was temporarily discontinued in 2015 (Volume 12) and resumed publication in 2017 (Volume 13) under its current title, the Brazilian Journal of Oncology (BJO).

The Brazilian Journal of Oncology launched with an expanded scope as an exclusively online journal, initially supported by the Sociedade Brasileira de Cirurgia Oncológica (Brazilian Society of Surgical Oncology) and the Sociedade Brasileira de Radioterapia (Brazilian Society of Radiotherapy). In May 2023, the Sociedade Brasileira de Oncologia Pediátrica (Brazilian Society of Pediatric Oncology) joined forces with these societies to co-sponsor the journal.

Aims & Scope

The Brazilian Journal of Oncology is the official publication of the Sociedade Brasileira de Oncologia Clínica – SBOC (Brazilian Society of Clinical Oncology), Sociedade Brasileira de Cirurgia Oncológica – SBCO (Brazilian Society of Surgical Oncology), and Sociedade Brasileira de Oncologia Pediátrica – SOBOPE (Brazilian Society of Pediatric Oncology).

The first issue of the Brazilian Journal of Oncology was published on March 30, 2017. In January 2019, the journal transitioned from publishing complete editions at fixed intervals to a continuous publication model. Under this model, articles are published online in their final form – complete with all bibliographic details – immediately after they are reviewed, approved, and formatted. This ensures a streamlined and efficient dissemination of research within annual volumes.

The journal publishes peer-reviewed clinical and translational studies across all areas of oncology, including clinical oncology, pediatrics, surgery, and radiation therapy. The Brazilian Journal of Oncology’s mission is to provide free, open-access to original research and reviews of innovative advances in oncology to improve clinical care for cancer patients.

The journal considers original papers, case reports, reviews (invited and submitted), editorial comments (invited), and letters to the editor. The journal may occasionally publish Special Articles, such as guidelines or other relevant documents.

The audience comprises medical professionals from diverse oncology disciplines, including medical, pediatric, surgical, radiation, hematologic, gynecologic, and urologic oncology. Readers include physicians, researchers, pharmacists, oncology nurses, and other healthcare practitioners with a predominant interest in oncology.

The Brazilian Journal of Oncology requires that authors follow the ICMJE (International Committee of Medical Journal Editors) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. More information can be found at https://www.icmje.org.

User Rights and Creative Commons Attribution

All articles published with open access are immediately and permanently free for anyone to read, download, copy, and distribute. Permitted third-party use and reuse are defined by the following Creative Commons user license:

Creative Commons Attribution (CC BY 4.0):

This license allows others to distribute and copy the article; create extracts, abstracts, or other revised versions; make adaptations or derivative works (such as translations); include the article in a collective work (such as an anthology); and perform text or data mining – even for commercial purposes. Users must provide appropriate credit to the author(s), must not imply endorsement by the author(s) of their adaptation, and must refrain from modifying the article in a manner that could harm the author’s honor or reputation.

CC BY 4.0 permits anyone to download, reuse, reprint, modify, distribute, and/or copy articles published in the Brazilian Journal of Oncology as long as the original authors and sources are properly cited. No permission is required from the authors or the publisher.

Author Rights and Copyright

Authors publishing in the Brazilian Journal of Oncology (ISSN 2526-8732) retain the copyright to their work. While the journal publishes the article, full intellectual property rights remain with the author(s). To ensure the broad dissemination of scholarly content, a publication agreement is required. The submitting author, acting with the consent of all co-authors, grants the Brazilian Journal of Oncology the right to publish the article. Should the manuscript be rejected or withdrawn during the peer-review process, this grant of rights is automatically revoked.

Third-Party Material

If the manuscript contains excerpts or elements from copyrighted works, the author(s) are responsible for obtaining written permission from the copyright holders and citing the sources. Proof of permission must be uploaded as a “Supplemental File NOT for Review” during submission. Proper acknowledgments must also be included in figure or table captions, in accordance with the Editorial Policy and the Instructions for Authors.

Responsibility for the accuracy of data, opinions, and concepts presented in the articles, including the validity of bibliographic references, rests entirely with the authors. These views do not necessarily reflect the position of the journal.

Fees and Compliance

There are no fees for submitting or publishing articles in the Brazilian Journal of Oncology. By submitting a manuscript, authors agree to comply with all requirements outlined in the Editorial Policy and Instructions.

1.1  Abstracting and indexing

DOAJ - Directory of Open Access Journals, LatIndex – Regional Cooperative Online Information System for Scholarly Journals from Latin America, the Caribbean, Spain and Portugal, LILACS – Latin-American and Caribbean Center on Health Sciences Information and Sumarios.Org – Sumários de Revistas Brasileiras.

1.2  Reasons to Publish

Web-based manuscript submission

Open Access publishing

Complete online access to all published articles

No Article Processing Charge (APC) or publication fees

Rigorous peer-review by leading specialists

High-quality editorial services

CC BY 4.0 license

Global readership